Psychiatric News (7/31) reports a study found that “nearly half of individuals who develop catatonia – a neuropsychiatric syndrome marked by abnormal speech and movements – will experience a relapse within a few years.” Considering this, “providing antipsychotics at discharge can reduce relapse risk.” The researchers “examined medical records of 303 patients who were treated for catatonia at a neuropsychiatric center in India between January 2014 and December 2017 and came back for at least one follow-up visit by December 2020.” They found that “48.8% of the patients experienced catatonia relapse, with most events occurring within the first two years after the initial episode.” They observed that “patients who received an antipsychotic prescription at discharge had a 41% reduced risk of relapse compared with those who did not; this reduced risk was present in patients with or without a prior history of catatonia.” The study was published in JAMA Psychiatry.
Related Links:
— “Antipsychotics May Reduce Risk of Catatonia Relapse, Psychiatric News, July 31, 2025